NewAmsterdam Pharma Company N.V.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2022 | $102.7M | $-3.6M | $-22.6M |
| FY2023 | $14.1M | $-183.0M | $-176.9M |
| FY2024 | $45.6M | $-176.3M | $-241.6M |
| FY2025 | $22.5M | $-225.7M | $-203.8M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2022 | $102.7M | $-3.6M | $-22.6M |
| FY2023 | $14.1M | $-183.0M | $-176.9M |
| FY2024 | $45.6M | $-176.3M | $-241.6M |
| FY2025 | $22.5M | $-225.7M | $-203.8M |